"I've had quite a few people contact me, but I'll place RBW right amongst the top. Highly professional, very personable, approachable and most importantly delivers results. Would highly recommend their services."

the team

Life Science & MedTech

Clinical

Alex Goodman
Consultant
Dominic Mitchell
Principal Consultant
Grace Ticehurst
Consultant
Robert Giarratani
Senior Recruitment Manager
Simon Penrose
Senior Consultant

Biometrics

Daniel Cheetham
Director
Daniel Knight
Consultant
Erick Semerene
Consultant
Geoff King
Principal Consultant
Harry Wooff
Consultant

Medical & PVG

Julie Robinson
Associate Divisional Lead
Marème Kaloga
Consultant (Medical, Clinical, HEOR)
Neil Machin
Associate Divisional Director
Ryan Winter
Senior Recruitment Manager
Sam Punt
Associate Divisional Director

Health Economics

Danielle Cohen
Divisonal Lead
Drew Bussey
Researcher
Ray Bird
Principal Consultant
Stefan Beck
Consultant

Regulatory Affairs & Quality Assurance

Antony Clark
Principal Consultant
Bobby DeMarco Jr.
Senior Recruitment Manager

Drug Discovery & Tech Ops

Ian Kulka
Principal Recruitment Manager
Tom Douglas
Consultant

Business Development

Adam Ball
Consultant
Georgia Desjarlais
Researcher
Sarah Rule
Senior Team Leader
Tamsynne Searle
Consultant

LATEST JOBS

Senior Statistical Programmer...
Join a niche Biotech and report directly into the Head of Stat Programming. ...
Director, Biostatistics ~ Pharma...
Minimum of 7 years relevant experience required...
Account Director / Medical ...
A multiple award-winning healthcare communications agency ...

Follow RBWConsulting

We are heading to #JSM2019 in Denver, Colorado towards the end of July. There is still time to register for the eve… https://t.co/iRXLRZJhwo
It is great to see many of the clients we are recruiting for included in this list which spam across many therapeut… https://t.co/1P4yREtbkR
Bluebird Bio’s gene therapy treatment for beta thalassemia Zynteglo is to be priced at €1.575m ($1.76m) in Europe,… https://t.co/8PFXwgnA53
Biogen has announced that it has completed its acquisition of Sycona’s Nightstar Therapeutics, the clinical-stage g… https://t.co/omxA5fOZDM
We are attending #OCTUK tomorrow and Wednesday in London. The team are available for meetings throughout the event… https://t.co/VtFRBJpz93